Following these proceedings, BTIG Research downgraded its Bionano Genomics Inc [BNGO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early January with a ‘”a Sector outperform”‘ rating.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of BNGO
On Tuesday, Bionano Genomics Inc [NASDAQ:BNGO] saw its stock fall -5.83% to $0.33. Over the last five days, the stock has lost -21.63%. Bionano Genomics Inc shares have fallen nearly -82.55% since the year began. Nevertheless, the stocks have fallen -85.14% over the past one year. While a 52-week high of $2.32 was reached on 01/02/24, a 52-week low of $0.31 was recorded on 08/08/24. SMA at 50 days reached $0.4469, while 200 days put it at $0.8655.
Levels Of Support And Resistance For BNGO Stock
The 24-hour chart illustrates a support level at 0.3185, which if violated will result in even more drops to 0.3073. On the upside, there is a resistance level at 0.3494. A further resistance level may holdings at 0.3691. The Relative Strength Index (RSI) on the 14-day chart is 30.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0649, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.40%. Stochastics %K at 4.46% indicates the stock is a buying.
How much short interest is there in Bionano Genomics Inc?
A steep rise in short interest was recorded in Bionano Genomics Inc stocks on 2024-09-30, growing by 2.39 million shares to a total of 6.07 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 3.68 million shares. There was a rise of 39.35%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 16, 2021 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $10 price target.
